| Watch time | Watch time | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Content | Views 4 |
(hours) | |||||||
| Total | 89,687 | 3,318.5 | |||||||
| CI | ~w. | Fluconazole | 31,955 | 35.6% | 681.3 | 20.5% | |||
| 0 | ~~: | Itraconazoie | 6,335 | 7.1% | 156.6 | 4.7% | |||
| Voriconazoie | 5,886 | 6.6' | 179.2 | 5.4 | |||||
| Cryptococcai | meningitis: | pathogenesis | and host respo... | 3,361 | 3.89' | 141.4 | 4.3 | ||
| Tinea capitis | (part 1/2) | 2,390 | 2.7 | 80.5 | 2.4% |
| General | Total | Total funds | ||||
|---|---|---|---|---|---|---|
| Unrestrict | Designated | funds | Year to | |||
| eil | funds | Year to | 30April | |||
| funds | 30April | 2022 | ||||
| Note | 2023 | 2023 | 2023 | |||
| INCOMING RESOURCES | ||||||
| Incoming resources from generated | funds | |||||
| Voluntary income: |
||||||
| Donations and grants |
2 | 44,533 | 44,533 | 20,918 | ||
| Activities for generating funds: |
||||||
| Investmentincome | 3 | 867 | 867 | 30 | ||
| Incoming resources from charitable | ||||||
| activities | ||||||
| Donations and grants |
4 | 29,000 | 29,000 | 11,435 | ||
| TOTAL INCOMING RESOURCES | 74,400 | 74,400 | 32,383 | |||
| RESOURCES EXPENDED | ||||||
| Costs ofcharitable activities |
||||||
| Charitable activities |
9,133 | 80,477 | 89,610 | 95,880 | ||
| Governance costs |
7,798 | 7,798 | 6,703 | |||
| TOTAL RESOURCES EXPENDED | 16,931 | 80,477 | 97,408 | 102,583 | ||
| NET MOVEMENT IN FUNDS | 57,469 | -80,477 | -23,008 | -70,200 | ||
| Transfers between funds | -36,061 | 36,061 | ||||
| Total Funds brought forward |
79,371 | 71,861 | 151,232 | 221,432 | ||
| TOTAL FUNDS CARRIED FORWARD | 100,779 | 27,445 | 128,224 | 151,232 |
| ONATIONS AND GRANT |
S | |||
|---|---|---|---|---|
| Total | Total | |||
| General | Designated | funds | funds | |
| Unrestricted | funds | Year to | Year to | |
| funds | 30April | 30April | ||
| 2023 | 2023 | 2023 | 2022 | |
| Gilead | 7,900 | |||
| Dynamiker | 3,535 | |||
| AAM | 29,000 | 29,000 | ||
| 29,000 | 29,000 | 11,435 |
| General | Total | Total | ||||
|---|---|---|---|---|---|---|
| Unrestricted | Designated | funds | funds | |||
| funds | funds | Year to | Year to | |||
| Note | 30April | 30April | ||||
| 2023 | 2023 | 2023 | 2022 | |||
| Donations | and grants | 9,133 | 9,133 | 82,854 | ||
| Project costs | 6 | 80,477 | 80,477 | 13,026 | ||
| Travel grants | ||||||
| Governance | costs | 7 | 7,798 | 7,798 | 6,703 | |
| 16,931 | 80,477 | 97,408 | 102,583 |
| General | Total | Total | |||||
|---|---|---|---|---|---|---|---|
| Unrestricted | Designated | funds | funds | ||||
| funds | funds | Year to | Year to | ||||
| 30April | 30April | ||||||
| 2023 | 2023 | 2023 | 2022 | ||||
| 8 | |||||||
| University of Manchester | Research Team | 30,162 | 30,162 | (10,000) | |||
| Other activity | costs | 50315 | 50,315 | 23,036 | |||
| 80,477 | 80,477 | 13,036 | |||||
| 7. GOVERNANCE COSTS |
|||||||
| Total | Total | ||||||
| General | Designated | flllltis | funds | ||||
| Unrestricted | funds | Year to | Year | to | |||
| funds | 30April | 30April | |||||
| 2023 | 2023 | 2023 | 2022 | ||||
| g | 8 | ||||||
| Insurance | 799 | 799 | 810 | ||||
| Legal and professional | 13 | 13 | 13 | ||||
| Travel and meeting costs | 1,721 | 1,721 | 150 | ||||
| Printing/postage/stationery | 442 | 442 | 458 | ||||
| Accountancy | fees | 1,250 | 1,250 | 1,200 | |||
| Bank charges | 111 | 111 | 162 | ||||
| Promotion Costs | 552 | 552 | |||||
| FITWebsite | Costs | 2,910 | 2,910 | 3,910 | |||
| 7,798 | 7,798 | 6,703 |
| 2023 | 2022 |
|---|---|
| 7,900 | |
| 2023 | 2022 |
| 8,673 | 20,248 |
| Expenditure, | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1May | Gains, losses | 30April | ||||||
| 2022I | income | &Tmnsfets | 2023 f. |
|||||
| Aspergillus Website |
83,374 | 20,412 | 62,962 | |||||
| Stella Huskisson | Memorial | Fund | 31,250 | 11,008 | 20,242 | |||
| LIFE-Worldwide | (42,763) | 12,996 | (55,759) | |||||
| 71,861 | 0 | 44,416 | 27,445 | |||||
| 1. | RECONCILIATION | OFMOVEMENTS | IN GENERAL FUNDS | |||||
| 2023 | 2022 | |||||||
| E | ||||||||
| Deficit (2021 surplus) ofincome over expenditure | forthe year | 21,408 | -25,846 | |||||
| Funds | at the beginning | ofthe | year | 79,371 | 105,217 | |||
| Funds | to carry forward | 100,779 | 79,371 |
| NALYSIS OFASSETSAND LIABILITIE | S BETWEEN FUNDS | ||
|---|---|---|---|
| General | Total | ||
| Unrestricted | Designated | funds | |
| funds | funds | 2023 | |
| f. | |||
| Current assets | |||
| Cash at bank and in hand | 102,089 | 34,808 | 136,897 |
| Debtors | |||
| Current liabilities | -1,310 | -7,363 | -8,673 |
| 100,779 | 27,445 | 128,224 |